Meezan Bank Ltd:企業の戦略・SWOT・財務情報

◆英語タイトル:Meezan Bank Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11846
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:パキスタン
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Meezan Bank Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Meezan Bank Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Meezan Bank Ltd (Meezan Bank) is a provider of banking and other financial products and services. The bank provides a range of corporate banking, investment banking, commercial banking, treasury and consumer banking products and services. Its portfolio of products include deposit products, saving accounts, certificates of deposit, personal loans, business loans, home loans, car loans, business loans and debit cards. The services offered by the bank are financing, asset management, investment services, trade services, investment banking services, treasury services, Islamic advisory services, online banking services, remittance services and money transfer services. It caters to individuals, corporate and institutional customers. The Bank distributes its products and services through a network of its branches and ATMs in Pakistan. Meezan Bank is headquartered in Karachi, Pakistan.

Scope

- Detailed information on Meezan Bank Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Meezan Bank Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Meezan Bank Ltd including a breakdown and examination of key business segments
- Intelligence on Meezan Bank Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Meezan Bank Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Meezan Bank Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Meezan Bank Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Meezan Bank Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Meezan Bank Ltd: Company Overview 9
Meezan Bank Ltd: Overview and Key Facts 9
Meezan Bank Ltd: Overview 9
Meezan Bank Ltd: Key Facts 9
Meezan Bank Ltd: Key Employees 11
Meezan Bank Ltd: Key Employee Biographies 13
Meezan Bank Ltd: Major Products and Services 14
Meezan Bank Ltd: Company History 15
Meezan Bank Ltd: Management Statement 18
Meezan Bank Ltd: Locations and Subsidiaries 19
Meezan Bank Ltd: Key Competitors 20
Meezan Bank Ltd: Company Analysis 21
Meezan Bank Ltd: Business Description 21
Meezan Bank Ltd: SWOT Analysis 22
Meezan Bank Ltd: SWOT Overview 22
Meezan Bank Ltd: Strengths 22
Meezan Bank Ltd: Weaknesses 23
Meezan Bank Ltd: Opportunities 23
Meezan Bank Ltd: Threats 23
Meezan Bank Ltd: Corporate Financial Deals Activity 25
Meezan Bank Ltd: Financial Deals Overview 25
Meezan Bank Ltd: Targets and Partners 27
Meezan Bank Ltd: Top Deals 2014 – 2018YTD* 28
Meezan Bank Ltd: Mergers and Acquisitions 29
Meezan Bank Ltd: Capital Raising 30
Meezan Bank Ltd: Recent Developments 31
Meezan Bank Ltd: News and Events Summary 31
Meezan Bank Ltd: Business Expansion 34
Meezan Bank Ltd: Contracts 35
Meezan Bank Ltd: Corporate Governance 36
Meezan Bank Ltd: Financial Deals 36
Meezan Bank Ltd: Regulatory and Legal Events 37
Meezan Bank Ltd: Strategy and Operations 37
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: Meezan Bank Ltd: Key Facts
Table 2: Meezan Bank Ltd: Key Employees
Table 3: Meezan Bank Ltd: Company History
Table 4: Meezan Bank Ltd: Locations and Subsidiaries
Table 5: Meezan Bank Ltd: Key Competitors
Table 6: Meezan Bank Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Meezan Bank Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Meezan Bank Ltd: Targets and Partners
Table 9: Meezan Bank Ltd: Top Deals 2014 - 2018YTD*
Table 10: Meezan Bank Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Meezan Bank Ltd: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Meezan Bank Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 13: Meezan Bank Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Table 14: Meezan Bank Ltd: News and Events Summary
Table 15: Meezan Bank Ltd: Business Expansion
Table 16: Meezan Bank Ltd: Contracts
Table 17: Meezan Bank Ltd: Corporate Governance
Table 18: Meezan Bank Ltd: Financial Deals
Table 19: Meezan Bank Ltd: Regulatory and Legal Events
Table 20: Meezan Bank Ltd: Strategy and Operations

List of Figures
Figure 1: Meezan Bank Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Meezan Bank Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Meezan Bank Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Meezan Bank Ltd: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Meezan Bank Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Meezan Bank Ltd: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Meezan Bank Ltd:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alteogen Inc (196170):製薬・医療:M&Aディール及び事業提携情報
    Summary Alteogen Inc (Alteogen) is a biotech company that develops proprietary antibody-drug conjugate and antibody biosimilars. The company’s pipeline products include ALT-P1, ALT-Q2, ALT-P7, ALT-Q5, ALT-L9 and ALT-L2. Its products are used for long-acting human growth hormone, long-acting factor V …
  • China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析
    China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Texas A&M University-製薬・医療分野:企業M&A・提携分析
    Summary Texas A&M University (TAMU) is a research based university that offers educational and research services. The university provides undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences …
  • J.B. Hunt Transport Services, Inc. (JBHT):企業の財務・戦略的SWOT分析
    J.B. Hunt Transport Services, Inc. (JBHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Bonavista Energy Corp (BNP):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonavista Energy Corp (Bonavista) is an intermediate energy company, which acquires, explores for, develops and produces oil and natural gas from its assets in the provinces of Alberta, British Columbia and Saskatchewan. Its core operations are concentrated in the Glauconite and Falher plays …
  • Creekside Springs, LLC:企業の戦略・SWOT・財務情報
    Creekside Springs, LLC - Strategy, SWOT and Corporate Finance Report Summary Creekside Springs, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CenterPoint Energy Inc (CNP):石油・ガス:M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • Symic Biomedical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation. The company’s ECM specific compounds facilitate local application, which enhances its a …
  • Dr. Ci:Labo Co., Ltd.:企業の戦略・SWOT・財務情報
    Dr. Ci:Labo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dr. Ci:Labo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ICI Pakistan Ltd (ICI):企業の財務・戦略的SWOT分析
    ICI Pakistan Ltd (ICI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Daily Mail and General Trust plc:企業のM&A・事業提携・投資動向
    Daily Mail and General Trust plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daily Mail and General Trust plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Alfresa Holdings Corp (2784):製薬・医療:M&Aディール及び事業提携情報
    Summary Alfresa Holdings Corp (Alfresa) is a manufacturer and marketer of pharmaceuticals, diagnostic reagent and medical devices. The company offers ethical pharmaceuticals wholesaling, self-medication products and manufacturing. It’s ethical pharmaceutical wholesaling business supplies diagnostic …
  • Capita plc:企業の戦略・SWOT・財務分析
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sonic Healthcare Ltd (SHL):企業の財務・戦略的SWOT分析
    Sonic Healthcare Ltd (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Guaranty Trust Bank Plc:企業の戦略・SWOT・財務情報
    Guaranty Trust Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Guaranty Trust Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ambac Financial Group, Inc.:企業の戦略・SWOT・財務分析
    Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sillajen Biotherapeutics (215600):製薬・医療:M&Aディール及び事業提携情報
    Summary Sillajen Biotherapeutics (SillaJen), formerly SillaJen Inc, is a biotechnology company that designs and develops oncolytic immunotherapeutics for the treatment of cancer. The company’s pipeline products comprise Pexa-Vec, an oncolytic immunotherapeutic virus which is in Phase III trial that …
  • RWE AG (RWE)-エネルギー分野:企業M&A・提携分析
    Summary RWE AG (RWE) is an energy company that generates, transmits and distributes electricity. The company generates electricity using various sources such as gas, hard coal, lignite, nuclear, hydro, biomass and renewables. It also produces oil, gas and lignite; and distributes and supplies gas. T …
  • IntegraGen SA (ALINT):製薬・医療:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • Cidara Therapeutics Inc (CDTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆